Prospective Cohort study of Female Oncofertility in Osaka
Not Applicable
Recruiting
- Conditions
- Adolescent and young adult women with newly diagnosed cancer, requiring anticancer treatment
- Registration Number
- JPRN-UMIN000053453
- Lead Sponsor
- Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients undergoing ovarian cryopreservation. 2. Patients who are judged by the investigator to be ineligible to participate in this research.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes are serum antimullerian hormone at fertility preservation (baseline), 1 and 2 years later. Odds ratio, 95% CI and p value are calculated using multivariate multiple regression analysis.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are serum FSH level, antral follicle counts, and amenorrhea at fertility preservation (baseline), 1 and 2 years later. Odds ratio, 95% CI and p value are calculated about serum FSH level and antral follicle counts using multivariate multiple regression analysis. Odds ratio, 95% CI and p value are calculated about amenorrhea using logistic regression analysis.